Zentalis Pharmaceuticals
ZNTL
ZNTL
122 hedge funds and large institutions have $1.61B invested in Zentalis Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 31 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
21% less capital invested
Capital invested by funds: $2.03B → $1.61B (-$423M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
122
Holding in Top 10
3
Calls
$1.53M
Puts
$17K
Top Buyers
| 1 | +$136M | |
| 2 | +$51.3M | |
| 3 | +$35.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$29.2M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$13.3M | |
| 3 | -$9.33M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$5.32M |
| 5 |
Renaissance Technologies
New York
|
-$5.04M |